临床病原微生物感染和纳米材料抗菌机制的研究。包括NTM、脓肿分枝杆菌和鲍曼不动杆菌等临床病原微生物的毒力和耐药以及和宿主的相互作用关系的机制研究；双金属MOFs和改性二氧化钛纳米复合物的抗菌作用机理研究。

Investigation of clinical pathogenic microbial infection and antibacterial mechanism of nanomaterials. Including the virulence and drug resistance of clinical pathogenic microorganisms such as NTM, Mycobacterium abscessis and Acinetobacter baumannii and the mechanism of interaction with the host; Research on the antibacterial mechanism of action of bimetallic MOFs and modified titanium dioxide nanocomposites.

中华医学会检验医学分会检验医学青年教师科研创新联盟委员；

中国中西医结合学会检验医学专业委员会分子诊断专家委员会委员；

中国防痨协会非结核分枝杆菌病专业分会委员；

上海市微生物学会临床微生物学专业委员会委员；

上海市医学装备协会实验医学专业委员会委员；

上海市医师协会检验医师分会管理学组组员；

上海市康复医学会检验与健康代谢学组组员；

Member of Laboratory Medicine Young Teachers Scientific Research and Innovation Alliance of Laboratory Medicine Branch of Chinese Medical Association ；

Member of the Molecular Diagnosis Expert Committee of the Laboratory Medicine Professional Committee of the Chinese Society of Integrative Medicine；

Committee member of the non tuberculosis mycobacterium Disease Branch, Anti-Tuberculosis Association of China；

Member of the Clinical Microbiology Committee of Shanghai Microbiology Society；

Member of Experimental Medicine Professional Committee of Shanghai Medical Equipment Association；

Member of the management group of the Laboratory Physician Branch of Shanghai Medical Doctor Association；

Member of Laboratory and Health Metabolism Group of Shanghai Rehabilitation Medical Association；

主持国家自然科学基金面上项目、青年基金和上海市科委西医引导项目等各类科研人才项目共7项。以第一作者或通讯作者发表SCI论著17篇，单篇最高IF为22.1分，10分以上5篇，其中Q1区论文8篇；参编专著2本；参与申请发明专利9项，其中7项已授权。

I am in charge of over 7 scientific research projects including National Natural Science Foundation of China, National Natural Science Foundation Youth Fund and Shanghai Municipal Science et al. Seventeen papers in journals such as JCM, EMI, ACS Appl. Bio Mater and Applied B: Environment etc. were published as the first or corresponding author format. The IF score of the five research papers were all above 10, while the highest was 22.1, including 8 papers in the first district(Q1). Participated in the editing of 2 monographs and applying for nine inventive patents, of which 7 were authorized.